Concordance of Inivata Liquid Biopsy With Standard Tissue Biopsy
NCT03116633 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34
Last updated 2019-05-16
Summary
This study aims to look at a comparison of liquid biopsy (blood sample) analysis compared with tissue biopsy in patients with advanced lung cancer
Conditions
Sponsors & Collaborators
-
Guardian Research Network, Inc.
collaborator OTHER -
Inivata
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-06-30
- Primary Completion
- 2018-05-31
- Completion
- 2018-12-31
Countries
- United States
Study Locations
More Related Trials
-
Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving Surgery
NCT05648370 ·Status: UNKNOWN
-
Evaluation of the Feasibility and Clinical Relevance of Liquid Biopsy in Patients With Suspicious Metastatic Lung Cancer
NCT03721120 ·Status: COMPLETED ·Phase: NA
-
Accelerating Lung Cancer Diagnosis Through Liquid Biopsy
NCT04863924 ·Status: ACTIVE_NOT_RECRUITING
-
Noninvasive vs. Invasive Lung Evaluation
NCT03615443 ·Status: COMPLETED
-
Study of Longitudinal Plasma PD-L1 Testing With Immunotherapy in Lung Cancer
NCT06849518 ·Status: RECRUITING ·Phase: NA
-
Liquid Biopsy for Early Non-small Lung Cancer Detection
NCT05462795 ·Status: COMPLETED
-
Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
NCT07168993 ·Status: RECRUITING ·Phase: NA
-
Fluid Biopsy for the Diagnosis of Lung Cancer
NCT04162678 ·Status: TERMINATED
-
Prediction of Response to PD-L1 Inhibitor After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer Using Multi-omics-based Liquid Biopsy
NCT06869239 ·Status: RECRUITING
-
Detection of Circulating Tumor DNA After Stereotactic Ablative Radiotherapy in Patients With Unbiopsied Lung Tumors
NCT05921474 ·Status: UNKNOWN
-
Liquid Biopsy in Lung Cancer
NCT03479099 ·Status: COMPLETED
-
Blood Sample Collection in Subjects Participating in a Lung Cancer Screening Program
NCT03628638 ·Status: COMPLETED
-
Real-Time Optical Biopsy in Improving Lung Cancer Diagnosis in Patients Undergoing Lung Biopsy
NCT03376971 ·Status: COMPLETED ·Phase: NA
-
A Study to Examine Biomarkers From Lung and Blood Samples in Participants With Suspected Lung Cancer
NCT04951154 ·Status: COMPLETED
-
An Observational Study on the Assessment of Lung Cancer Using Liquid Biopsy for Collecting miRNA Expression Profile and DNA Methylation Biomarkers.
NCT07182214 ·Status: RECRUITING
-
Biomarkers in Tissue and Blood Samples From Patients With Early-Stage Non-Small Cell Lung Cancer
NCT01139944 ·Status: COMPLETED
-
Liquid Biopsy for Detection of Driver Mutation in NSCLC
NCT02778854 ·Status: UNKNOWN
-
Detection of Genetic Markers of Lung Cancer
NCT00280202 ·Status: RECRUITING
-
Construction and Evaluation of the Liquid Biopsy-based Early Diagnostic Model for Lung Cancer
NCT04156360 ·Status: UNKNOWN
-
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients
NCT04566432 ·Status: RECRUITING
-
Liquid Biopsy-Based Novel Modality for Postoperative Management of Lung Cancer
NCT06930807 ·Status: RECRUITING ·Phase: NA
-
The Correlation of PD-L1 Expression in Non-small Lung Cancer Tissue and Peripheral Blood T Cell and Serum.
NCT03073902 ·Status: COMPLETED
-
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
NCT00003006 ·Status: COMPLETED
-
Assessment of Early-detection Based on Liquid Biopsy in Lung Cancer (ASCEND-LUNG)
NCT04817046 ·Status: UNKNOWN
-
Molecular Profiling and Dynamic Changes of ctDNA in Unresectable Locally Advanced NSCLC
NCT05641870 ·Status: UNKNOWN